Skip to content

Transperineal prostate biopsy under local anaesthetic compared to general anaesthetic for men with suspected prostate cancer

Local Anesthetic Transperineal Prostate Biopsy (LATProBE) Trial - A trial to assess the tolerability and efficacy of transperineal prostate biopsy under local anaesthetic compared to general anaesthetic for men with suspected prostate cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620001145998
Acronym
LATProBE
Enrollment
620
Registered
2020-11-02
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study to assess the safety and efficacy of two transperineal prostate biopsy methods Who is it for? You may be eligible to join this study if you are male and have a clinical suspicion of prostate cancer (PCa) and are scheduled to undergo a prostate biopsy. Patients with a previous diagnosis of PCa on active surveillance are included. Study details Participants in this study will be allocated to one of two biopsy groups. Participants will undergo single diagnostic freehand transperineal prostate biopsy performed either under local anaesethetic (intervention) or template grid biopsy under general anaesthetic (control) by a qualified urologist. This will take place in a public hospital. We will assess proportion of patients with prostate cancer positive biopsies, pain score during biopsy procedure and patient satisfaction as well as any complications. The aim of this study is to show that local anaesthetic transperineal prostate biopsy is a safe and just as accurate as prostate biopsy under general anaesethesia. Another aim is to show it is more efficient in terms of health economics therefore can be adopted by more public hospitals and ultimately widen the access to prostate biopsy for patients.

Interventions

Single diagnostic freehand transperineal prostate biopsy performed either under local anaesethetic (intervention) or template grid biopsy under general anaesthetic (control) by a qualified urologist. This will take place in a public hospital. 1) Freehand transperineal prostate biopsy is a procedure performed whilst the patient is awake. Local anaesthetic (1% lignocaine, 10-15ml injected into perineal skin and peri-prostatic) is used to anaesthetise the perineum and prostate, and a probe is ins

Single diagnostic freehand transperineal prostate biopsy performed either under local anaesethetic (intervention) or template grid biopsy under general anaesthetic (control) by a qualified urologist. This will take place in a public hospital. 1) Freehand transperineal prostate biopsy is a procedure performed whilst the patient is awake. Local anaesthetic (1% lignocaine, 10-15ml injected into perineal skin and peri-prostatic) is used to anaesthetise the perineum and prostate, and a probe is inserted into the rectum to take core biopsies of the prostate gland. Effectiveness of anaesthetic is tested by the clinician gentle placing a sharp instrument (i.e. tissue forceps) onto the perineal skin and asking the patient if they feel pain. If the anaesthetic is effective - the biopsy is completed. 'Freehand' means the surgeon is in control of the probe and directs the core biopsy device accordingly to the area of interest 2) Template grid biopsy is performed under general anaesthesia (as per anaesthetist discretion) so the patient is asleep for the whole procedure. Similarly a probe is inserted into the rectum to visualise the prostate but the biopsies are taken as per a per-determined guide (i.e. a grid) which allows a set template of biopsies to be taken from the prostate.

Sponsors

Monash Health Department of Urology
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Diagnosis
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Male patients • Clinical suspicion of prostate cancer – elevated PSA, abnormal DRE or suspicious lesion on MRI • Previous diagnosis of PCa patients on active surveillance still included • At least medically fit for trans-perineal prostate biopsy at least under general anaesthesia • Adequate mobility to sit in lithotomy position

Exclusion criteria

• Allergic reaction to local anaesthetic • Patient refusal

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026